AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Lineage Cell Therapeutics, Inc.

$1.00 -$0.64 (-39.02%)
AMEX · 30 Oct 2026 20:00 UTC
Previous Close
$1.03
Day Range
$0.98$1.04
Year Range
$0.88$2.09
Market Cap
252.91M
AVG Volume
1.42M
Trailing/Forward PE
-7.13/-
PEG ratio
0.09
Dividend Yield
-
Next Earnings Date
2026-11-05
Primary Exchange
New York Stock Exchange ArcaUS
Revenue (USD) · TTM
05M10M15M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
LCTX Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q213.08M
26 Q114.78M
25 Q414.56M
25 Q310.82M
25 Q210.91M
25 Q19.56M
24 Q49.5M
24 Q38.72M
24 Q26.19M
24 Q18M
Net Income (USD) · TTM
-80M-60M-40M-20M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
LCTX Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-32.26M
26 Q1-64.21M
25 Q4-63.53M
25 Q3-67.66M
25 Q2-40.91M
25 Q1-16.21M
24 Q4-18.61M
24 Q3-20.11M
24 Q2-24.19M
24 Q1-23.66M
Operating Income (USD) · TTM
-40M-30M-20M-10M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
LCTX Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-26.85M
26 Q1-37.71M
25 Q4-36.62M
25 Q3-35.18M
25 Q2-35.23M
25 Q1-21.32M
24 Q4-21.48M
24 Q3-22.73M
24 Q2-25.59M
24 Q1-24.75M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: LCTX

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 5 Nov 2026.

Lineage Cell Therapeutics, Inc.
LCTX
Stockpicker

Video analysis: LCTX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: LCTX

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.